|
End-of-day quote
Buenos Aires S.E.
16/11/2026
|
5-day change | 1st Jan Change | ||
| 77,475.00 ARS | +0.29% |
|
-0.32% | +9.82% |
| 04:09pm | Roche Secures First U.S. Approval for New Breast-Cancer Pill | DJ |
| 11-17 | Rhythm drug shows sustained weight reduction in patients with brain damage-related obesity | RE |
| Market Cap | 287B 444,327B 261B 241B 218B 411B 26,957B 425B 2,898B 1,148B 14,466B 1,077B 1,054B 45,822B | P/E 2026 * |
24.3x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 308B 476,569B 280B 258B 233B 441B 28,913B 456B 3,108B 1,232B 15,516B 1,155B 1,131B 49,147B | EV / Sales 2026 * |
4.86x | EV / Sales 2027 * | 4.46x |
| Free-Float |
96.36% | Yield 2026 * |
1.8% | Yield 2027 * | 1.91% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| AZN | End-of-day quote | |
| AZND | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | +0.29% | ||
| 1 week | -0.32% | ||
| Current month | +0.32% | ||
| 1 month | +15.72% | ||
| 3 months | +25.87% | ||
| 6 months | +15.08% | ||
| Current year | +9.82% |
| 1 week | 76,550 | 78,575 | |
| 1 month | 66,450 | 81,150 | |
| Current year | 60,650 | 81,150 | |
| 1 year | 60,650 | 81,150 | |
| 3 years | 24,288 | 81,150 | |
| 5 years | 5,438.5 | 81,150 | |
| 10 years | 214.5 | 81,150 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Pam Cheng
COO | Chief Operating Officer | 55 | 01/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.29% | -0.32% | - | - | 287B | ||
| -0.14% | -0.55% | +39.42% | +140.73% | 1,275B | ||
| -0.44% | -0.21% | +40.38% | +87.05% | 680B | ||
| -0.32% | -0.59% | +24.85% | +111.24% | 521B | ||
| -0.82% | +1.02% | +41.33% | +70.83% | 389B | ||
| -0.00% | -3.13% | +54.44% | +40.94% | 356B | ||
| -1.40% | -0.68% | +26.26% | +58.81% | 305B | ||
| -1.48% | -0.69% | +1.44% | +34.39% | 287B | ||
| -0.50% | -1.34% | +34.32% | +72.95% | 250B | ||
| +2.13% | -0.75% | +36.67% | +124.77% | 208B | ||
| Average | -0.32% | +0.51% | +33.23% | +82.41% | 475B | |
| Weighted average by Cap. | -0.37% | +0.76% | +35.30% | +96.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.38B 98,088B 57.58B 53.2B 48.05B 90.68B 5,951B 93.87B 640B 253B 3,193B 238B 233B 10,115B | 67.39B 104,304B 61.23B 56.57B 51.1B 96.43B 6,328B 99.82B 680B 270B 3,396B 253B 248B 10,756B |
| Net income | 11.69B 18,096B 10.62B 9.81B 8.87B 16.73B 1,098B 17.32B 118B 46.77B 589B 43.87B 42.95B 1,866B | 13.58B 21,014B 12.34B 11.4B 10.29B 19.43B 1,275B 20.11B 137B 54.31B 684B 50.95B 49.87B 2,167B |
| Net Debt | 20.83B 32,242B 18.93B 17.49B 15.8B 29.81B 1,956B 30.86B 210B 83.32B 1,050B 78.17B 76.52B 3,325B | 13.65B 21,123B 12.4B 11.46B 10.35B 19.53B 1,281B 20.22B 138B 54.59B 688B 51.21B 50.13B 2,178B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | ARS 77,475.00 | +0.29% | 205 |
| 13/11/26 | ARS 77,250.00 | +0.16% | 262 |
| 12/11/26 | ARS 77,125.00 | -0.10% | 429 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions


















